MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0146330
Stempeutics Research Private Limited - life sciences in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.88 Cr
▲ 96% YoY
Net loss · FY 2025
₹12.84 Cr
Net margin -71.8%
EBITDA · FY 2025
-₹12.48 Cr
EBITDA margin -69.8%
Authorised capital
₹65 Cr
Registered with MCA
Paid-up capital
₹63.62 Cr
Issued & subscribed
Open charges
₹1.89 Cr
Satisfied ₹28.44 Lakh
Company age
20 yrs
Est. 2006
Employees · EPFO
27
Provident fund records
About Stempeutics Research Private Limited
Data last updated:
Stempeutics Research Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2006PTC038256. Its GSTIN is 29AAJCS8177Q1Z4 (Karnataka).
The company has an authorised share capital of ₹65 Cr and a paid-up capital of ₹63.62 Cr. It is led by directors including Manohar Balu Narasimhan (Managing Director) and Hebri Sudarshan Ballal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor #143 212 – 215 Epip Industrial Area Hoodi Village K.R.Puram Hobli, Bengaluru, Karnataka, India – 560066.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.88 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net loss of ₹12.84 Cr (net margin -71.8%) and EBITDA of -₹12.48 Cr (EBITDA margin -69.8%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 14% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stempeutics. As per MCA filings, the company has open charges of ₹1.89 Cr and satisfied charges of ₹28.44 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 21 deals on record (8 funding rounds, 6 secondary share transfers, 5 rights issues), with disclosed funding of ₹133.9 Cr; the latest was in May 2022. The company has 6 MSME Form 1 returns on record between 2019 and 2023, listing 18 overdue payments to 9 micro and small suppliers.
Stempeutics Research Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0146330). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stempeutics.com.
Company details
CIN U73100KA2006PTC038256
Registration Number 038256
Incorporation Date 16 January 2006
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0146330
Key People
Manohar Balu Narasimhan Managing Director Jaideep Ashok Gogtay Nominee Director Hebri Sudarshan Ballal Director Recognitions & Rankings of Stempeutics Research
Contact details
Stempeutics Research Private Limited's registered office is in Bengaluru, Karnataka. Its website is stempeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor #143 212 – 215 Epip Industrial Area Hoodi Village K.R.Puram Hobli, Bengaluru, Karnataka, India – 560066
- IndustryLife Sciences, Biotechnology
To see the full contact details of Stempeutics Research Private Limited, buy the company report.
Comprehensive company report
Stempeutics Research Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Stempeutics Research operates one associated brand: Stempeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Stem-cell-based products are developed for osteoarthritis and Buerger's disease. | stempeutics.com |
Business activity
The main business activity of Stempeutics Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Stempeutics Research Private Limited, buy the company report.
Financials of Stempeutics Research Private Limited
FY 2025 filings availableStempeutics Research Private Limited reported revenue of ₹17.88 Cr (up 96% YoY) for FY 2025.
Revenue · FY 2025
₹17.88 Cr ▲ 96%
Net loss · FY 2025
₹12.84 Cr margin -71.8%
EBITDA · FY 2025
-₹12.48 Cr margin -69.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 96%
3 years · compounded
▲ 79%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 27%
3 years · compounded
▼ 5%
5 years · compounded
▼ 38%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 96% growth in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -69.8% | ||||
| Net Profit Margin | -71.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stempeutics Research Private Limited, buy the company report.
Board of directors of Stempeutics Research Private Limited
Stempeutics Research has 5 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaideep Ashok Gogtay Also directs: Sitec Labs Limited | Nominee Director | 28 Mar 2019 | 7 Years 7 Months | Current |
| Hebri Sudarshan Ballal | Director | 19 Jan 2012 | 14 Years 9 Months | Current |
| Umang Vohra Also directs: Cohance Lifesciences Limited, Cipla Health Limited | Director | 24 Feb 2023 | 3 Years 8 Months | Current |
| Anurag Bagaria | Director | 27 Jun 2019 | 7 Years 4 Months | Current |
| Manohar Balu Narasimhan | Managing Director | 26 Aug 2009 | 17 Years 2 Months | Current |
Auditor
Stempeutics Research Private Limited is audited by A Krishna Kumar & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A Krishna Kumar & Co. | FY 2023 | 012424S |
Shareholding
The shareholding of Stempeutics Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stempeutics Research Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.89 Cr
Satisfied charges
₹28.44 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2011 | 10337194 | Biotechnology Industry Research Assistance Council | ₹1.89 Cr | Open | |
| 19 Nov 2021 | 100506817 | Hdfc Bank Limited | ₹28.44 Lakh | Satisfied |
To see the full charge records of Stempeutics Research Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Stempeutics Research Private Limited has 21 deals on record (8 funding rounds, 6 secondary share transfers, 5 rights issues), with disclosed funding of ₹133.9 Cr; the latest was in May 2022.
Total deals
21
Funding rounds
8
Secondary share transfers
6
Rights issues
5
Acquisition
1
Disclosed funding
₹133.9 Cr
Deals on record (5 of 21)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Funding round | ₹36 Cr | Investors: Max Medisupport LLP |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: Manipal Healthcare Private Limited Seller: MEMG Family Office |
| Apr 2021 | Rights issue | ₹20 Cr | Investors: Max Medisupport LLP |
| Jul 2020 | Rights issue | ₹5 Cr | Investors: Max Medisupport LLP |
| May 2019 | Rights issue | ₹39.15 Cr | Investors: Max Medisupport LLP , MEMG Family Office Seller: an individual |
To see the full deal history of Stempeutics Research Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stempeutics Research Private Limited has 1 court case on record: 1 filed by Stempeutics Research. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Tax appeal | Filed by the company against The Joint Director of Income Tax | Disposed |
To see the full case history of Stempeutics Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Stempeutics Research Private Limited has 6 MSME Form 1 returns on record between 2019 and 2023, listing 18 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aic Enterprises Private Limited | |||
| Sequel Logistics Private Limited | |||
| Writer Business Services Private Limited | |||
| Indigo Copier Services (MSME) | |||
| Indigo Copier Services |
To see the full MSME payment records of Stempeutics Research Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Stempeutics Research Private Limited has a workforce of 27 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
-3.57%
GST
Stempeutics Research has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCS8177Q1Z4 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stempeutics Research Private Limited, buy the company report.
Recent activity
Stempeutics Research Private Limited has 19 board changes on record since 2007: 5 appointments and 14 cessations. The latest: Umang Vohra ceased to be Additional Director on 16 Jul 2023.
Charges
A charge registered on 19 Nov 2021 via Charge ID 100506817 with Hdfc Bank Limited was fully satisfied on 17 Oct 2025.
AGM
Stempeutics Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stempeutics Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Umang Vohra ceased to be Additional Director.
Ceased
Ramkumar Krishnaswamy Mandalam ceased to be Nominee Director.
Appointed
Umang Vohra was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100506817 was registered on 19 Nov 2021.
Appointed
Anurag Bagaria was appointed as Director.
Appointed
Jaideep Ashok Gogtay was appointed as Nominee Director.
Ceased
Vikram Sudarsan Penubolu ceased to be Director.
Ceased
Chandru Jaswant Chawla ceased to be Additional Director.
Ceased
Steven Bruce Lehrer ceased to be Director.
14 earlier events are in the company report.
News
Frequently asked questions
Stempeutics Research is an active private limited company based in Bengaluru, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 January 2006 (20+ years old) and is registered under CIN U73100KA2006PTC038256.
Stempeutics Research has 5 current directors:
- Manohar Balu Narasimhan - Managing Director
- Jaideep Ashok Gogtay - Nominee Director
- Hebri Sudarshan Ballal - Director
- Umang Vohra - Director
- Anurag Bagaria - Director
The latest financial statements of Stempeutics Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stempeutics Research is 29AAJCS8177Q1Z4, registered in Karnataka.
The CIN (Corporate Identification Number) of Stempeutics Research is U73100KA2006PTC038256. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stempeutics Research has 1 court case on record: 1 filed by the company.
Stempeutics Research was incorporated on 16 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
Stempeutics Research has 21 deals on record (8 funding rounds, 6 secondary share transfers, 5 rights issues), with disclosed funding of ₹133.9 Cr; the latest was in May 2022.
Umang Vohra ceased to be Additional Director on 16 Jul 2023. Ramkumar Krishnaswamy Mandalam ceased to be Nominee Director on 31 Mar 2023. Umang Vohra was appointed as Director on 24 Feb 2023. Stempeutics Research has 19 board changes on record in total.
Yes, Stempeutics Research is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0146330).
Stempeutics Research has 6 MSME Form 1 returns on record between 2019 and 2023, listing 18 overdue payments to 9 micro and small suppliers. The latest return was filed on 24 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages